Elevation Oncology Inc. Gains 17.84%

Wed, Apr 27, 2022 at 05:30 PM
Elevation Oncology Inc. Gains 17.84%

Elevation Oncology Inc. (ELEV:NASDAQ) shot up at $2.84, representing a gain of 17.8%. The stock got featured on our News Catalysts scanner on Wed, Apr 27, 2022 at 10:09 AM in the 'BIOTECH' category. From Wed, Apr 13, 2022, the stock recorded 50.00% Up Days and 44.44% Green Days

The share price of the company has been moving sideways in recent weeks.

About Elevation Oncology Inc. (ELEV:NASDAQ)

Elevation Oncology Inc is an oncology company focused on the development of targeted therapeutics for the treatment of cancer in genomically defined patient populations.

Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.